Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2026-01-13 @ 9:05 AM
Study NCT ID:
NCT01791400
Status:
COMPLETED
Last Update Posted:
2013-02-15
First Post:
2013-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache
Sponsor:
Isfahan University of Medical Sciences
Organization:
Study Overview
Official Title:
Study of Effects of Metoclopramide Versus Sumatriptan on Migraine Headache
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine which drug makes lower migraine headache
Detailed Description:
There are different options to manage benign headache in emergency department.The investigators compared Intravenous metoclopramide with Subcutaneous sumatriptan to relieve pain in emergency department.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: